# CORRESP — Ensysce Biosciences, Inc.  (ENSC, ENSCW)  (CIK 0001716947)

> <strong>Ensysce Biosciences, Inc.  (ENSC, ENSCW)  (CIK 0001716947) → SEC staff</strong> · filed 2026-04-14 · ticker ENSC, ENSCW · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001493152-26-016449
- **Form:** CORRESP
- **Filer:** Ensysce Biosciences, Inc.  (ENSC, ENSCW)  (CIK 0001716947)
- **CIK:** 0001716947
- **Ticker:** ENSC, ENSCW
- **Filed:** 2026-04-14
- **SIC industry:** 2834
- **HQ:** La Jolla, CA

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1716947/000149315226016449/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1716947&type=UPLOAD&dateb=&owner=include&count=40

## Other comment-letter activity for Ensysce Biosciences, Inc.  (ENSC, ENSCW)  (CIK 0001716947)

- UPLOAD — 2026-04-13 — /comment-letter/0000000000-26-003700

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, Ensysce Biosciences, Inc.  (ENSC, ENSCW)  (CIK 0001716947) (CIK 0001716947), filed 2026-04-14, accession 0001493152-26-016449. Retrieved via MORVS 2026-11-04 from https://api.morvs.ai/comment-letter/0001493152-26-016449.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*